Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Method: Consecutive patient sampling. Patients were included in the study in consecutive manner if they fulfilled the inclusion criteria and any of the exclusion criteria were not present.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Manic and mixed episodes of up to moderate severity in patients with Type I and II bipolar disorder and schizoaffective disorder; either first diagnosed or repeated episodes
You may not be if
Hypersensitivity to ziprasidone
prolonged QTc interval
coadministration with substances that are prolonging the QTc interval
recent acute MI, cardiac failure, patients with arrhythmias treated with class IA or III medicaments
Clareo Health | Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.